Skip to content
LP
Exempt Reporting Adviser · CRD 329146Private Fund Adviser

Updated:

Legacy Pharma Invest GP

Legacy Pharma Invest GP manages pharma-exit wealth through direct healthcare investments, concentrating on pharma services and specialty manufacturing.

Overview

Legacy Pharma Invest GP Inc. is a Toronto-based investment adviser since 2024.

General information

Firm type

Exempt Reporting Adviser

Sector focus

PharmaceuticalsHealthcare Services

Frequently asked questions

Where does Legacy Pharma Invest GP source its deals?

Deal flow is proprietary and relationship-driven, rooted in the principals' network within the pharmaceutical services ecosystem. The firm does not maintain a public-facing brand, website, or intermediary-heavy sourcing model, which limits its pipeline to opportunities introduced through personal contact and sector reputation alone.

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Explore more profiles